Glimicron

Glimicron

gliclazide

Manufacturer:

Hovid

Distributor:

DCH Auriga - Healthcare
Concise Prescribing Info
Contents
Gliclazide
Indications/Uses
NIDDM.
Dosage/Direction for Use
Adult 40-80 mg daily, may gradually increase up to 320 mg daily. Doses >160 mg daily should be given in 2 divided doses.
Administration
Should be taken with food.
Contraindications
Acidosis, burns, diabetic coma, infection, ketoacidosis, ketosis, surgery & trauma; severe renal, hepatic or thyroid impairment; pregnancy.
Special Precautions
Adrenal insufficiency, pituitary insufficiency, fever, nausea, vomiting, debilitated physical condition, malnourishment, acute porphyria, fluid retention, renal, hepatic & thyroid impairment. Elderly.
Adverse Reactions
GI disturbances; rash & pruritus; severe, prolonged & sometimes fatal hypoglycaemia; hypersensitivity reactions including cholestatic jaundice, leucopenia, thrombocytopenia, aplastic anaemia, agranulocytosis, haemolytic anaemia, erythema multiforme or Stevens-Johnson syndrome, exfoliative dermatitis & erythema nodosum; SIADH; photosensitivity.
Drug Interactions
Alcohol, rifampicin, thiazide diuretics, corticosteroids, estrogens, chloramphenicol, guanethidine, MAOIs, salicylates, sulfonamides, trimethoprim, phenylbutazone, ketoconazole, miconazole, fluconazole, sulphinpyrazone & azapropazone, ketotifen, β-blockers, insulin, anticoagulants.
MIMS Class
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glimicron tab 80 mg
Packing/Price
10 × 10's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in